Case study · pharma
A mid-sized European pharmaceutical firm preparing a new cardiovascular drug launch needed a unified team-merchandise program for 350 medical representatives across 12 EU member states — team apparel, physician gift sets, and detailing materials that hold up under regulatory review and field use.
A mid-sized European pharmaceutical firm — headquartered in Prague, with a manufacturing plant in Hradec Kralove — was preparing the market launch of a new cardiovascular drug. The product received EMA (European Medicines Agency) approval in September 2025, with market entry across 12 EU member states planned for March 2026. A core element of the launch strategy was equipping 350 field-based medical representatives with team apparel and a structured set of detailing materials and physician gift sets.
The company adopted a team-branding approach: pressed and embroidered shirts, hooded sweatshirts, doctor gift sets, and detailing aids. The goal was to strengthen the team's visual identity at cardiology congresses, sales meetings, and clinic visits, while giving representatives practical, regulation-compliant tools to introduce the new molecule to prescribing physicians.
The approved program budget was CZK 4.8 million net of VAT — covering garments, gift sets, detailing materials, and last-mile distribution into 12 EU countries. The brief set two concrete targets: 350 outfitted representatives and 12,000 gift sets distributed to physicians across the 12 markets.
The firm approached Corp-Merch on the strength of a prior engagement (congress merchandise for the Czech Pharmaceutical Congress in April 2025). The brief covered 350 shirts, 350 hooded sweatshirts, 12,000 physician gift sets, detailing materials (roll-up banners, brochures, sample kits), and international distribution into 12 EU member states.
The program pulled four service lines together into one coordinated launch package rather than four separate transactions.
350 men's and women's shirts in a classic cut, made from 100% organic cotton, GOTS-certified. Six-colour chest embroidery in Madeira Polyneon thread. Sizes S through XXL. Selected for the formal look required at clinic visits and cardiology congresses. Delivered into 12 EU member states.
350 unisex hooded sweatshirts in 80% organic cotton and 20% recycled polyester, GOTS-certified. Company logo and product name embroidered on the back. Sizes S through XXL. Selected for informal events and colder-weather wear. Delivered into 12 EU member states.
12,000 gift sets in recycled-cardboard gift boxes, FSC-certified. Each set contained: a metal laser-engraved pen, an A5 notepad on FSC paper, two rolled product brochures, a placebo sample, and a branded gift box. The sets were produced in 12 language variants — Czech, Slovak, Polish, German, Austrian German, Hungarian, Romanian, Bulgarian, Italian, Spanish, French, and Dutch.
Distribution into 12 EU member states via specialised carriers — DHL Medical Express and UPS Healthcare. No customs clearance was required inside Schengen and the EU; VAT was handled under reverse charge per Section 196 of the Czech VAT Act on cross-border deliveries. Local coordination with the firm's country offices kept transit at three to five business days per country.
The shirts were manufactured at a partner facility in Brno: 12 working days for the full 350-piece run, including logo embroidery. The hoodies came from a Portuguese manufacturer: 14 working days for the full 350-piece run. The physician gift sets were assembled at Corp-Merch's headquarters — five working days for the full 12,000-piece batch.
Gift-set assembly covered: 12 language variants (each country received its own localised version), placebo-sample compliance review against SUKL (the Czech State Institute for Drug Control) requirements, and gift-box checks against the firm's brand manual. Quality control ran on 100% of the 12,000 sets, with each of the five component items verified per unit.
International distribution covered: 12 destinations (Czechia, Slovakia, Poland, Germany, Austria, Hungary, Romania, Bulgaria, Italy, Spain, France, and the Netherlands); two carrier tiers (DHL Medical Express for shipments over 50 kg, UPS Healthcare for less urgent loads); and coordination with the firm's 12 country-level contact persons.
Invoicing was issued in CZK with 21% VAT in ISDOC format (mandatory in Czechia since January 2025). Cross-border deliveries were invoiced under reverse charge per Section 196 of the Czech VAT Act, with the recipient accounting for VAT via its own return. The invoice carried a 60-day net payment term. The client's internal SAP ERP ingested the ISDOC files without issue.
The program moved through four phases: (1) brief and concept approval (four weeks), (2) supplier selection, localisation, and sampling (four weeks), (3) serial production and assembly (six weeks), and (4) international distribution and follow-up (two weeks). End-to-end lead time from brief approval to completed distribution was 16 weeks.
Phase 1 — Brief and approval: first intake from the pharma firm, consulting on product mix, internal concept sign-off across marketing, regulatory affairs, legal, and the ethics committee. Four weeks — extended on this engagement due to the internal regulatory review chain.
Phase 2 — Supplier selection and localisation: sample pulls (three shirt variants, three hoodie variants, three gift-set variants), text localisation into 12 languages with native-speaker review, and sign-off on final artwork. Four weeks.
Phase 3 — Serial production and assembly: shirt production (12 working days), hoodie production (14 working days), gift-set component production (five working days), assembly of 12,000 sets (five working days), and full quality control. Six weeks including the overlap between workstreams.
Phase 4 — International distribution: delivery into 12 EU markets (three to five days per country), coordination with country offices, invoicing, and documentation archival. Two weeks of active logistics.
Outcome measurement rested on four KPIs: schedule adherence, complaint rate, rep satisfaction, and new-prescription revenue lift in the 90-day post-launch window.
Schedule adherence: planned completion was 16 weeks from brief approval; actual completion was 16 weeks and three days — a three-day slip driven by delayed Romanian text localisation. Distribution across all 12 markets landed within the planned three-to-five-day transit window.
Complaint rate: 38 complaints received across the 12,000 distributed gift sets, an overall rate of 0.32%. Breakdown: (a) 14 complaints about an error in the Romanian-language variant, (b) 9 complaints about a damaged gift box, (c) 7 complaints about a missing placebo sample, (d) 8 complaints about shirt sizing. All complaints were resolved within 14 working days.
Rep satisfaction: an internal survey two weeks after distribution (180 respondents out of 350 representatives, a 51% response rate). 87% of respondents rated the team apparel as "high quality" or "very high quality", 11% as "average", and 2% as "below average". Most frequent positive comments: "the shirt looks polished", "the hoodie is comfortable", "the gift set reads as elegant".
New-prescription lift: in the 90-day post-launch window, the firm recorded an 18% increase in new prescriptions for the cardiovascular product. The share attributable to the launch program — including the merchandise component — was approximately 22% of that lift; the remainder was attributed to the broader marketing campaign and individual rep effort. The pharma firm assessed the overall program as "very good, fully aligned with regulatory requirements".
Standard production runs 12 to 14 working days from sample approval. Express production of seven to ten working days is available for selected colours and size runs.
Minimum order is 500 sets per language. For a 12,000-set run across 12 languages like the one in this case study, we recommend a 3 to 5% overage.
No. Corp-Merch is an independent B2B merchandise vendor. In this case study, we delivered merchandise for the pharma firm as a client. The pharmaceutical firm is a client of Corp-Merch, not a partner or sponsor.
Distribution runs through DHL Medical Express or UPS Healthcare. No customs clearance is needed within Schengen and the EU; VAT follows reverse charge under Section 196 of the Czech VAT Act. Transit time is three to five business days per country.
This case study documents a real B2B merchandise engagement for a pharmaceutical firm acting as client. The drug launch received EMA (European Medicines Agency) and SUKL (Czech State Institute for Drug Control) approvals. Corp-Merch is not a partner, sponsor, or official supplier of the pharmaceutical firm. Any reference to the drug product serves only as context for the client's B2B merchandise program.
Project details (volumes, budget, schedule) are real but anonymised to protect client confidentiality. Specific prescription and revenue figures cited here are illustrative and may differ from the actual outcomes on this engagement.
All certifications (GOTS, GRS, FSC, OEKO-TEX, LFGB) and GDPR compliance were observed. Invoices were issued in ISDOC format at 21% VAT in CZK — with reverse charge applied on cross-border deliveries — and documentation is retained for ten years under pharmaceutical audit requirements.
This case study does not offer financial outcomes as a universal guarantee. The success of any B2B launch program depends on the brief, the product mix, and the quality of execution.
Working on a comparable launch program? Get in touch — we will prepare a pricing estimate and timeline based on your brief.
Start with what you know. We’ll work through the details together.